Today: 30 April 2026
Browse Category

ASX:CSL 24 December 2025 - 26 January 2026

CSL share price rises on ASX as U.S. vaccine policy shifts rattle the sector

CSL share price rises on ASX as U.S. vaccine policy shifts rattle the sector

CSL Ltd shares closed 0.7% higher at A$179.62 Friday, extending Thursday’s gains, with 1.01 million shares traded. The stock’s rise comes as U.S. vaccine policy changes under Health Secretary Robert F. Kennedy Jr. weigh on sentiment for CSL’s Seqirus unit. CSL delayed a Seqirus spinoff and cut its 2026 growth forecast in October, citing falling U.S. flu vaccination rates. Half-year results are due Feb. 11.
23 January 2026
···
CSL share price slips after close as RBC upgrade turns focus to Feb. 11 results

CSL share price slips after close as RBC upgrade turns focus to Feb. 11 results

CSL shares closed down 0.33% at A$176.11 on Wednesday, staying well below last year’s highs. RBC Capital upgraded CSL to “Outperform” and raised its price target to A$230, citing valuation upside despite weak U.S. flu vaccine demand. Investors are focused on CSL’s half-year results and interim dividend due Feb. 11. The S&P/ASX 200 slipped 0.37% amid broader market volatility.
21 January 2026
··
CSL share price edges up after RBC upgrade as investors eye February results

CSL share price edges up after RBC upgrade as investors eye February results

CSL shares rose 0.1% to A$176.70 Tuesday after RBC Capital Markets upgraded the stock, despite the ASX 200 falling 0.66%. The move follows a 36% drop in CSL’s share price over the past year and comes ahead of its Feb. 11 half-year results. RBC cited competition and weak flu vaccine demand as near-term risks. CSL last cut its 2026 revenue and profit growth forecasts in October and delayed its Seqirus spin-off.
20 January 2026
·
CSL share price slips after ASX close: what investors watch next for ASX:CSL ahead of February results

CSL share price slips after ASX close: what investors watch next for ASX:CSL ahead of February results

CSL Ltd shares fell 1.0% to A$173.32 Tuesday, underperforming the S&P/ASX 200, which rose 0.56%. The drop follows last year’s cut to CSL’s FY26 forecasts and a delay to the Seqirus spin-off after a sharp decline in U.S. flu vaccinations. No new company updates were released Tuesday. CSL’s next scheduled disclosure is its half-year results on Feb. 11.
13 January 2026
···
CSL Limited (ASX:CSL) Stock Update on 24 December 2025: Share Price Drops, Buyback Progress, Seqirus Uncertainty, and 2026 Analyst Forecasts

CSL Limited (ASX:CSL) Stock Update on 24 December 2025: Share Price Drops, Buyback Progress, Seqirus Uncertainty, and 2026 Analyst Forecasts

CSL Limited shares closed at A$171.48 on 24 December 2025, down 2.38%, near their 52-week low of A$168.00. The company delayed the spin-off of its Seqirus vaccine arm and cut its FY26 outlook after a sharper-than-expected drop in US flu vaccination rates. Market value stands at about A$85.5 billion. Shares are down roughly 39% over the past year.
24 December 2025
·
1 2 3 4

Stock Market Today

  • Shivalik Bimetal Controls Insider Buying Boosts Stock Value to ₹104.5m
    April 29, 2026, 8:23 PM EDT. Shivalik Bimetal Controls Limited (NSE:SBCL) insiders saw their ₹67.8 million investment rise to ₹104.5 million following a 12% stock price increase that added ₹3.8 billion to the company's market value. Insider purchases totaling ₹68 million over the past year, including a ₹34 million buy by Whole Time Director Sumer Ghumman at ₹394 per share, were made well below the current price of ₹602. No insider sales were reported, indicating strong confidence in the company. Insiders hold about 23% of total shares, valued near ₹7.9 billion, suggesting alignment with shareholders. These insider activities and holdings signal a bullish outlook on Shivalik Bimetal's prospects amid market optimism.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Go toTop